Effect of New Evidence on Antithrombotic Therapies in Atrial Fibrillation Patients Who Undergo Percutaneous Coronary Intervention in Alberta, Canada

Background: Trials have addressed the combined use of direct oral anticoagulants (DOACs) and antiplatelets in atrial fibrillation (AF) patients undergoing percutaneous coronary intervention (PCI). These trials may have changed prescribing patterns. Methods: This administrative audit of Albertans wit...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Theresa E. Eberhardt, PharmD, ACPR, Tammy J. Bungard, BSP, PharmD, Michelle M. Graham, MD, FRCPC, FCCS, Michelle Picard, BScPharm, ACPR, Grace T. Wang, MMath, Margaret L. Ackman, BScPharm, PharmD, ACPR, FCSHP
Format: Artigo
Langue:Inglês
Publié: Elsevier 2022-04-01
Collection:CJC Open
Accès en ligne:http://www.sciencedirect.com/science/article/pii/S2589790X21003565
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires